Association of a Healthy Lifestyle with All-Cause and Cause-Specific Mortality among Individuals with Type 2 Diabetes: A Prospective Study in UK Biobank
Han,Yaying Cao,Chengwu Feng,Yan Zheng,Klodian Dhana,Shu Zhu,Cong Shang,Changzheng Yuan,Geng Zong
DOI: https://doi.org/10.2337/dc21-1512
2021-01-01
Diabetes Care
Abstract:Objective:To evaluate the association of a healthylifestyle, involving seven low-risk factors mentioned in diabetes managementguidelines (no current smoking, moderate alcohol consumption, regular physicalactivity, healthy diet, less sedentary behavior, adequate sleep duration, andappropriate social connection), with all-cause and cause-specific mortalityamong individuals with type 2 diabetes. Research Design andMethods: This study included 13,366 participants with baseline type 2 diabetesfrom the UK Biobank free of CVD or cancer. Lifestyle information was collectedthrough a baseline questionnaire.Results:During a median follow-up of 11.7 years, 1,561 deaths were documented, with 625from cancer, 370 from CVD, 115 from respiratory disease, 81 from digestivedisease, and 74 from neurodegenerative disease. In multivariate-adjusted model, eachlifestyle factor was significantly associated with all-cause mortality and hazardratios (95% CIs) associated with the lifestyle score (scoring 6-7 vs. 0-2unless specified) were 0.42 (0.34, 0.52) for all-cause mortality, 0.57 (0.41,0.80) for cancer mortality, 0.35 (0.22, 0.56) for CVD mortality, 0.26 (0.10,0.63) for respiratory mortality, and 0.28 (0.14, 0.53) for digestive mortality(scoring 5-7 vs. 0-2). In the population-attributable-risk analysis, 27.1% (95%CI: 16.1, 38.0%) death was attributable to a poor lifestyle (scoring 0-5). The association between a healthylifestyle and all-cause mortality was consistent, irrespective of factorsreflecting diabetes severity (diabetes duration, glycemiccontrol, diabetes-related microvascular disease, and diabetes medication).Conclusions:Ahealthy lifestyle was associated with a lower risk of mortality due toall-cause, CVD, cancer, respiratory disease, and digestive disease amongindividuals with type 2 diabetes.